ReferIndia News FDA's Bold Move Boosts Biosimilars, US-China Tensions Over Fentanyl, Artificial Cornea Innovation

ReferIndia News

Sponsored

आज का राशिफल पढ़ें — जानें आपका दिन कैसा रहेगा

Check Now
News Image

FDA's Bold Move Boosts Biosimilars, US-China Tensions Over Fentanyl, Artificial Cornea Innovation

Published on: March 11, 2026, 2:30 a.m. | Source: Devdiscourse

Today's health news spotlight includes the FDA's proposal to streamline biosimilar drug testing to reduce costs, heightened US-China disagreements over fentanyl at the UN, and noteworthy advancements by Spanish researchers in developing a cost-effective artificial cornea. These developments highlight ongoing global health challenges and innovations.

Checkout more news
Ad Banner

वसई-विरार में बेहतरीन सर्जरी हॉस्पिटल की तलाश?

VHMC हॉस्पिटल — वसई-विरार में भरोसेमंद सर्जरी और आधुनिक इलाज का नाम, जहाँ मरीजों की सेहत हमारी पहली प्राथमिकता है।

संपर्क करें
ReferIndia News contact